NREP
NEW REPRESENTATIVE AT IB RECEIVED
27/04/2024
Voltar para busca
Dado oficial do USPTO
GOURI
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
25
Atualização mais recente
27/04/2024
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
3, 5, 10
Data de depósito
12/04/2021
Data de registro
16/08/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/08/2022
Última transação
16/08/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
03
Localização do titular
KR
Examinador
GAGLIARDI, JEANINE
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
DexLevo Inc.
Representantes
Lenny R. Jiang Paratus Law Group, PLLC
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Functional cosmetics being skin care preparations; anti-aging cosmetic preparations; make-up; cosmetic preparations for skin care; anti-wrinkle creams for cosmetic purposes; wrinkle removing skin care preparations; cosmetic preparations consisting of colloidal solutions; cosmetic preparations consisting of colloidal solutions for contouring wrinklessoreslipsface and bodyskin renewal and filling; cosmetic preparations in the nature of cosmetic materials for skin renewal and filling; wrinkle minimizing cosmetic preparations for topical facial use; cosmetic preparations for skin renewal; cosmetic preparations
Classe 5
Pharmaceuticals for cosmetic surgery or dermatological use; pharmacological preparations for skin care in the nature of pharmaceutical preparations for skin care; pharmacological preparations for facial correction in the nature of dermatological pharmaceutical products; injectable solutions for improving facial contour in the nature of injectable dermal filler; medicated liquid preparations in ampoules in the nature of medicated skin care preparations; surgical implants comprised of living tissues; drugs for medical purposes in the nature of pharmaceutical preparations for treating skin disorders; injectable dermal tissue fillers for medical purposes; medicinal infusions for treating dermatological conditions; pharmaceuticals in the nature of pharmaceutical preparations for treating dermatological conditions; medicines for human purposespharmaceutical preparations for treating dermatological conditions; implants comprising living tissue for guided tissue regeneration; injectable dermal fillers for anti-wrinkle purposes; injectable medicinal solutions to minimize wrinkles in the nature of injectable dermal fillers; injectable dermal fillers; implantable medicines in the nature of implants comprising living tissue; injectable preparations for facial contour improvement for therapeutic purposes in the nature of dermal fillers; injectable dermal tissue fillers consisting of colloidal solutions for medical purposes; pharmaceutical preparations consisting of colloidal solutions for medical purposesfor treating dermatological conditionsused for contouring wrinklessoreslipsface and bodyskin renewal and filling; skin grafts; pre-filled syringes for medical purposes sold filled with injectable dermal tissue fillers; skin grafts for medical purposes
Classe 10
Artificial implants for cosmetic and esthetic surgery; drug syringes in the nature of medical syringes; medical instrumentsmedical syringes; medical apparatus and instruments in the nature of medical syringes; syringes for medical purposes; medical skin care apparatus in the nature of medical skin abraders; medical apparatus and instruments for cosmetic and plastic surgery; medical apparatus for injecting fillers in the nature of medical syringes; medical filler syringes in the nature of medical syringes; liquefied artificial implants for contouring wrinklessoreslipsface and bodyskin renewal and filling; liquid formed artificial implants consisting of colloidal solutions for medical purposes; artificial implants for skin regeneration; medical syringes for the skin; medical apparatus and instruments for the treatment of skinmedical apparatus for measuring skin hydration and phototherapeutic apparatus in the nature of an LED light source for medical skin treatments
Publicações
Histórico de despachos e eventos da marca no USPTO.
25 publicações encontradas
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/11/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
21/12/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
29/11/2022
FIMP
FINAL DISPOSITION PROCESSED
29/11/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
16/11/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
16/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
16/08/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/05/2022
PUBO
PUBLISHED FOR OPPOSITION
31/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/04/2022
RFNT
REFUSAL PROCESSED BY IB
23/01/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/12/2021
RFRR
REFUSAL PROCESSED BY MPU
30/12/2021
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/12/2021
CNRT
NON-FINAL ACTION WRITTEN
02/12/2021
DOCK
ASSIGNED TO EXAMINER
02/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
13/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GOURI ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.